Intravesical injections of botulinum neurotoxin A to treat overactive bladder and/or detrusor overactivity related to multiple sclerosis: 5-Year continuation rate and specific risk factors for discontinuation-A study from the neuro-urology committee of the French Association of Urology.
Mult Scler
; 29(8): 1024-1032, 2023 07.
Article
de En
| MEDLINE
| ID: mdl-37264947
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Urologie
/
Vessie neurologique
/
Toxines botuliniques de type A
/
Vessie hyperactive
/
Sclérose en plaques
/
Agents neuromusculaires
Type d'étude:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limites:
Humans
Langue:
En
Journal:
Mult Scler
Sujet du journal:
NEUROLOGIA
Année:
2023
Type de document:
Article
Pays d'affiliation:
France
Pays de publication:
Royaume-Uni